Cyclosporin A toxicity , and more : vascular endothelial growth factor ( VEGF ) steps forward

mapping of the SLEB2 locus involved in susceptibility to systemic lupus erythematosus. Genomics 2000; 70: 307–314 20. Savill J, Dransfield I, Gregory C, Haslett C. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat Rev Immunol 2002; 2: 965–975 21. Scott RS, McMahon EJ, Pop SM et al. Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 2001; 411: 207–211 22. d’Agnillo P, Levine JS, Subang R, Rauch J. Prothrombin binds to the surface of apoptotic, but not viable, cells and serves as a target of lupus anticoagulant autoantibodies. J Immunol 2003; 170: 3408–3422 23. Anderson HA, Maylock CA, Williams JA et al. Serumderived protein S binds to phosphatidylserine and stimulates the phagocytosis of apoptotic cells. Nat Immunol 2003; 4: 87–91 24. Yasutomo K, Horiuchi T, Kagami S et al. Mutation of DNASE1 in people with systemic lupus erythematosus. Nat Genet 2001; 28: 313–314 25. Lachmann PJ. The in vivo destruction of antigen – a tool for probing and modulating an autoimmune response. Clin Exp Immunol 1996; 106: 187–189 26. Pepys MB, Lanham JG, de Beer FC. C-reactive protein in SLE. Clin Rheum Dis 1982; 8: 91–103 27. Licht R, Jacobs CW, Tax WJ, Berden JH. No constitutive defect in phagocytosis of apoptotic cells by resident peritoneal macrophages from pre-morbid lupus mice. Lupus 2001; 10: 102–107 28. Grootscholten C, van Bruggen MC, van der Pijl JW et al. Deposition of nucleosomal antigens (histones and DNA) in the epidermal basement membrane in human lupus nephritis. Arthritis Rheum 2003; 48: 1355–1362